Aurinia Pharmaceuticals Inc (AUPH): Very Excited about this Friday's Voclosp...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	1
Posts	52
Boards Moderated	0
Alias Born	01/28/2017

ThePromise247

Re: None

Monday, 10/16/2017 5:57:59 AM

Monday, October 16, 2017 5:57:59 AM

Very Excited about this Friday's Voclosporin Indications Announcement!

Some of the indication possibilities could be worth an additional half a billion dollars annually (on top of the $1,000,000,000 plus >> Projected Annual Revenue from Lupus Nephritis), like taking away Roche Pharmaceutical's annual $500,000,000 market share, for their "anti organ-transplant rejection drug".

Another strong indication possibility could be "Psoriasis", and of course, don't forget that indication Dr. Glickman recently mentioned on CNBC's Jim Cramer's Mad Money... "Dry Eye".
And don't forget guys, Voclosporin has already "successfully" gone through previous Clinical Trials for both
Anti Organ-Transplant Rejection, and Psoriasis.
Add everything up, and AUPH could potentially be earning $2,000,000,000 plus >> Annually.

Hoping someone with better financial projection skills could comment on what they see AUPH's share price range going up to?